; and (5) encourage graduate and post-graduate research to include detection and identification of xylazine and other emerging substances of concern in relevant course studies when practicable. (c) Controls In carrying out activities under this section, the Director shall ensure proper security controls are implemented to protect sensitive information, as the Director considers appropriate and consistent with applicable provisions of law. (d) Report Not later than 1 year after the date of the enactment of this Act, the Director shall submit to the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Science, Space, and Technology of the House of Representatives a report on the implementation of this section. Such report may include recommendations for legislative action to improve the ability of the Director to carry out this section. 3. Study on United States Government technologies and analytical methods to detect and identify new psychoactive substances (a) Study (1) In general The Comptroller General of the United States shall conduct a study of the capabilities of the Federal Government to respond to the threats of new psychoactive substances such as xylazine. (2) Matters evaluated The study conducted pursuant to paragraph (1) shall include an evaluation of the following: (A) The capabilities, including technologies and analytical methods, of Federal, State, and local agencies to detect and identify new psychoactive substances such as xylazine. (B) An analysis of timeframes for identification and development of technologies and methods to identify new psychoactive substances by Federal, State, and local agencies. (C) Facilities, including laboratories, used by Federal, State, and local agencies for the identification of new psychoactive substances such as xylazine. (D) Federal grant programs to fund new technology development to detect and identify new psychoactive substances. (b) Report Not later than 2 years after the date of the enactment of this Act, the Comptroller